張有德 (Yue-Teh Jang)
Education:
B.S.Materials Science and Engineering, National Tsing-Hua University, Taiwan 1976
Ph.D.Materials Science and Engineering, University of Utah 1984
Executive Program Stanford university 1992
Experience:
2013-Present Chairman, President and CEO, MedeonBiodesign
A Taiwan based medical device company focusing on incubation and development of innovative products to meet unmet clinical needs
2000-2012 General Partner, The Vertical Group
A venture fund for medical device and biotech investments and incubation
2002-2006 Co-Founder, President and CEO, Ensure Medical
A medical device start-up company focusing on cardiovascular devices which was successfully acquired by Johnson and Johnson in July, 2003
2000-2003 Co-Founder, President and CEO, Integrated Vascular Systems (IVS)
A medical device company developing vessel closure technology which was successfully acquired by Abbott Laboratories in August 2003
2001 President and CEO, Kyphon (Symbol:KYPH)
A medical device company developing technologies to treat vertebral body compression fracture and spinal deformation.Kyphon went public in 2002 and was acquired by Medtronic for $3.9 billion
- President and CEO, EMBOL-X
A medical device to develop embolic protection devices for cardiology and cardiosurgery. Technologies were acquired by Boston Scientific Corporation and Edwards Lifesciences, respectively
- Vice President of Corporate R&D, Boston Scientific Corporation (Symbol:BSX)
BSX is a medical device company with revenues of $7 billion focusing on minimally invasive technologies for diagnostic and therapeutic applications
- Vice President R&D, Cardiovascular Imaging Systems (Symbol:CVIS)
A medical device company for intravascular ultrsound imaging technology. Company went IPO in 1992 and was acquired by BSX in 1995
- Director of R&D, Mallinckrodt (Acquired by Tyco)
1982-1984 Research Scientist, Deseret Medical (Acquired by Beckton Dickinson)
Publications:
Numerous journal publications on materials science and medical devices.Inventor/co-inventor of over 50 US and international patents on biomaterials and medical devices.
Current Board Seats:
MedeonBio, MedeonBiodesign, Delta Asia International, iXensor, Tricorntech, Panther Orthopedics, Aquedeon, Inc.
Committee Services and Honors:
Past President and Board member of Taiwanese American Industrial Technology Association (TAITA-SV)
Former Steering Committee member, Hsin-Chu Bio Park, Taiwan
Member, BioTaiwan Committee (BTC), Executive Yuan, Taiwan
Board member, ITRI International
Advisor, Bioelectronics and Medical Device Center, ITRI
Member, Advanced R&D Advisory Committee, ITRI
Initiator and Advisor, Stanford Taiwan Biomedical (STB) Fellowship Program
Distinguished Alumnus, School of Engineering, National Tsing-Hua University, Taiwan
Distinguished Alumnus, National Tsing Hua University, Taiwan
Honorary Distinguished Professor, National Tsing Hua University, Taiwan
Honorary Professor, National Cheng Kung University, Taiwan
Steering Committee, Medical Device Innovation Center, National Cheng Kung University, Taiwan
Founding member, SVT Angel Group
Yue-Teh Jang is currently the President and CEO of Medeon Biodesign, a Taiwan based medical device product development and investment group.
Dr. Jang spent the last 13 years as general partner of The Vertical Group and has more than 30 years of experience in various executive positions in the health care industry. He was President and Chief Executive Officer of Embol-X, Ensure Medical, Integrated Vascular System, and Kyphon. Prior to that time, Dr. Jang was vice-president for corporate R&D at Boston Scientific, vice-president for R&D at Cardiovascular Imaging Systems, a project manager with Mallinckrodt Medical, and a scientist with Deseret Medical. He currently serves on the Boards of Directors of Inphenix,Medeon Biodesign, Tricorntech, iXensor and Somnics.
Dr. Jang received a B.S. in Materials Science from National Tsing-Hua University, Taiwan and a Ph.D. in Materials Science from the University of Utah.